Paragon nabs $15M filovirus vax contract from DoD

The U.S. Department of Defense has awarded Paragon Bioservices, a contract manufacturing organization, a $15 million contract to develop a mammalian process to manufacture vaccines for filoviruses, which are considered potential bioweapons.  Paragon also has been working on vaccines that would guard against the Ebola and related Marburg viruses. Story